The Data
/
Stocks
/ BDX
Equity · Healthcare
BDX
NYSE
Becton, Dickinson and Company
$191.59
−1.11% vs prior close
Finazon · prior-day close, indicative (IEX-derived, not the official close) · Oct 16, 2026
1D
1M
3M
1Y
5Y
All
Price · Chart
63 sessions
The line runs $153.85 on 21 July through $191.59 on 16 October, on a scale from $140 to $200. Days the market did not trade hold the previous close, flat.
Interactive BDX price chart by TradingView (requires JavaScript).
Market cap
$52.2B
52-week range
$140.68 – $210.09
Avg volume
104.6K
as of Oct 16, 2026
About Becton, Dickinson and Company
Becton, Dickinson and Company develops, manufactures, and sells medical devices, including the BD Alaris™ Infusion System. The company serves customers in the United States and internationally, and its products are subject to regulatory requirements such as FDA clearance and EU Medical Device and In Vitro Diagnostic Regulations. BD also operates under various privacy, data protection, and tax laws in multiple jurisdictions. The company addresses product recalls and compliance with evolving regulations, which can affect its operations and financial results.
Company
Founded
1897
Headquarters
Becton, Dickinson and Company headquarters
Exchange
NYSE
Sector
Healthcare
Class
Equity
Insiders Form 4
Filings 5 sets
BDX insider trades
SEC Form 4 · last 90 days · newest reported trade 28 Sep 2026
Open-market buys
0
Open-market sells
5
Net sold
$1.27M
Non-trade filings
4
Date
Insider
Type
Shares
Value
28 Sep 2026
Feld Michael
EVP, Chief Revenue Officer
Sell
76
$14K
26 Aug 2026
Feld Michael
EVP, Chief Revenue Officer
Sell
165
$31K
13 Aug 2026
Polen Thomas E Jr
Chairman, CEO and President
Sell
4,152
$768K
11 Aug 2026
Goette Roland
EVP and President, EMEA
Sell
2,438
$441K
27 Jul 2026
Feld Michael
EVP, Chief Revenue Officer
Sell
75
$12K
Compensation mechanics
Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.
Date
Insider
Type
Shares
Value
02 Sep 2026
Roque Vitor
EVP & Chief Financial Officer
Tax withheld
190
20 Aug 2026
Feld Michael
EVP, Chief Revenue Officer
Tax withheld
1,049
13 Aug 2026
Polen Thomas E Jr
Chairman, CEO and President
Option exercise
43,278
$7.24M
13 Aug 2026
Polen Thomas E Jr
Chairman, CEO and President
Other
39,126
$7.24M
BDX reported financials
SEC EDGAR XBRL
SEC EDGAR
BDX reported revenue of $21.8B for the fiscal year ended 30 Sep 2025. Net income over the same period was $1.7B.
Figure
Reported
Period
Revenue
$21.8B
30 Sep 2025
fiscal year
Net income
$1.7B
30 Sep 2025
fiscal year
Diluted EPS
$5.82
30 Sep 2025
fiscal year
Total assets
$50.7B
30 Jun 2026
at period end
Total equity
$24.4B
30 Jun 2026
at period end
BDX earnings
SEC EDGAR
Date
Period
EPS
Revenue
30 Jun 2026
Q3 2026
$1.37
$4.98B
31 Mar 2026
Q2 2026
−$1.11
$4.71B
31 Dec 2025
Q1 2026
$1.34
$5.25B
30 Sep 2025
FY 2025
$5.82
$21.84B
30 Jun 2025
Q3 2025
$2.00
$4.73B
31 Mar 2025
Q2 2025
$1.07
$4.48B
31 Dec 2024
Q1 2025
$1.04
$5.17B
30 Sep 2024
FY 2024
$5.86
$20.18B
Next report no date announced in SEC filings yet
Reported figures & scheduled dates · SEC EDGAR filings
9 of the 45 institutional funds we track reported a BDX position for the quarter ended 30 Jun 2026 — a combined $229.2M; the latest of those filings landed 02 Sep 2026.
BDX fails-to-deliver
SEC CNS data
SEC
On 21 Sep 2026, 1,691 shares of BDX failed to deliver (about $306K).
Settlement date
Shares failed
Notional
% of shares out
21 Sep 2026
1,691
$306K
0.001%
09 Sep 2026
127
$23K
<0.001%
04 Sep 2026
2,217
$416K
0.001%
The most recent congressional trade disclosed in BDX is a sale by Thomas H. Kean, Jr. (house, NJ), dated 21 May 2026.
Date
Member
Type
Amount
21 May 2026
filed 18 Jun 2026
Thomas H. Kean, Jr.
house · Republican–NJ
Sale
$1K–$15K
17 Mar 2026
filed 03 Apr 2026
Kevin Hern
house · Republican–OK
Sale
$15K–$50K
24 Jun 2025
filed 13 Aug 2025
Lisa C. McClain
house · Republican–MI
Sale
$1K–$15K
17 Jun 2025
filed 13 Aug 2025
Lisa C. McClain
house · Republican–MI
Purchase
$1K–$15K
15 May 2025
filed 09 Jun 2025
Robert P. Bresnahan, Jr.
house · Republican–PA
Purchase
$1K–$15K
13 May 2025
filed 17 Jun 2025
Thomas H. Kean, Jr.
house · Republican–NJ
Purchase
$1K–$15K
08 Apr 2025
filed 28 Apr 2025
Robert P. Bresnahan, Jr.
house · Republican–PA
Sale
$1K–$15K
05 Mar 2025
filed 11 Apr 2025
Jefferson Shreve
house · Republican–IN
Sale
$15K–$50K
Sources
Finazon prior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
TradingView the price chart widget, drawn by TradingView from their own data
SEC EDGAR SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
SEC EDGAR SEC EDGAR 13F filings
SEC SEC fails-to-deliver (CNS) data
House disclosures U.S. House of Representatives financial disclosures
SEC EDGAR Valuation computed from SEC EDGAR filings